New combo shot study: could VAX-31 plus flu vaccine be a Game-Changer for seniors?
NCT ID NCT07365826
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests a new vaccine called VAX-31, which protects against 31 types of pneumonia-causing bacteria. It is given together with the seasonal flu shot to healthy adults aged 50 and older. The goal is to see if giving both vaccines at the same time is safe and works as well as getting them separately. About 1,390 participants will be followed for 7 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL VACCINES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR Knxoville
Knoxville, Tennessee, 37909, United States
-
AMR Lexington
Lexington, Kentucky, 40509, United States
-
Accel Research Sites - Lakeland
Lakeland, Florida, 33803, United States
-
Accel Research Sites - Largo
Largo, Florida, 33777, United States
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
CenExel JBR Clinical Research
Salt Lake City, Utah, 84107, United States
-
CenExel Research Centers of America
Hollywood, Florida, 33024, United States
-
Charlottesville Medical Research Center
Charlottesville, Virginia, 22911, United States
-
Clinical Research Partners, LLC.
Richmond, Virginia, 23226, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
DM Clinical Research - Detroit
Detroit, Michigan, 48076, United States
-
DelRicht Research - Hendersonville
Hendersonville, Tennessee, 37075, United States
-
Epic Medical Research
DeSoto, Texas, 75115, United States
-
Health Awareness
Jupiter, Florida, 33458, United States
-
Health Research of Hampton Roads, Inc.
Newport News, Virginia, 23606, United States
-
Hope Research Institute
Phoenix, Arizona, 85032, United States
-
Johnson County ClinTrials
Lenexa, Kansas, 66219, United States
-
Precision Clinical Research
Sunrise, Florida, 33351, United States
-
REX Clinical Trials
Beaumont, Texas, 77701, United States
-
Rochester Clinical Research
Rochester, New York, 14609, United States
-
Tekton Research at Austin
Austin, Texas, 78745, United States
-
Tekton Research at Fort Collins
Fort Collins, Colorado, 80525, United States
-
University Clinical Research - Deland
DeLand, Florida, 32720-0834, United States
-
Velocity Omaha
Omaha, Nebraska, 68134, United States
-
Velocity Valparaiso
Valparaiso, Indiana, 46383, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New vaccine targets 26 pneumococcal strains in early trial
- New 25-Valent pneumonia vaccine shows promise in phase 2 trial
- New pneumonia vaccine VAX-31 aims to boost protection in older adults
- Can a pneumonia vaccine protect the most vulnerable children?
- New vaccine aims to outsmart pneumonia bacteria
- New baby vaccine aims to beat pneumonia: VAX-31 trial underway